CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | MicrobiomeTrials← Back to trialsNCT07335497
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-17Est. Completion: 2029-02
Enrollment target: 290 participants Locations- Clinical Study Site, Los Angeles, California, United States
- Clinical Study Site, Denver, Colorado, United States
- Clinical Study Site, Orlando, Florida, United States
- Clinical Study Site, Sarasota, Florida, United States
- Clinical Study Site, Detroit, Michigan, United States
- Clinical Study Site, Grand Rapids, Michigan, United States
- Clinical Study Site, New York, New York, United States
- Clinical Study Site, Columbus, Ohio, United States
- Clinical Study Site, Nashville, Tennessee, United States
- Clinical Study Site, Dallas, Texas, United States
- Clinical Study Site, San Antonio, Texas, United States
- Clinical Study Site, West Valley City, Utah, United States
- Clinical Study Site, South Brisbane, Queensland, Australia
- Clinical Study Site, Cluj-Napoca, Cluj, Romania
- Clinical Study Site, Seoul, Seoul, South Korea
- Clinical Study Site, Seoul, Seoul, South Korea
- Clinical Study Site, Seoul, Seoul, South Korea
Other microbiome trials you might be interested in
Advanced Melanoma and Normal or ImpairedAdvanced Melanoma
This study is a first-in-human, open-label, nonrandomized, single center Phase 1 dose-escalation study to assess the saf…
New Haven, United StatesEst. completion Aug 2027
IO-resistant sqNSCLC
Lung cancer is one of the most common forms of cancer. One common type is non-small cell lung cancer (NSCLC). NSCLC happ…
Jonesboro, United StatesEst. completion Nov 1, 2028